The pharmaceutical industry is witnessing a significant shift in the reformulation of injectable drug products for nasal delivery. This article presents a case study of using modelling to accelerate the reformulation process. The focus is on Nanopharm’s SmartTrack™, a process that combines breath profiles recording with realistic aerodynamic particle size distribution performance testing, in-vitro dissolution, and morphology directed particle sizing and chemical imaging of a representative lung dose and regional deposition modelling.
Inhalation
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
The acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities strengthens Aptar Pharma’s service portfolio to meet growing demand for early-phase clinical trial support and innovation.
July 18, 2025
No Comments
